These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25274860)

  • 1. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
    Pracon R; Opolski MP; Mintz GS; Pregowski J; Kruk M; Popma JJ; Mandinov L; Wang H; Ellis SG; Grube E; Dawkins KD; Stone GW; Weissman NJ
    J Invasive Cardiol; 2014 Oct; 26(10):501-11. PubMed ID: 25274860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.
    Weissman NJ; Turco MA; Ormiston JA; Mann T; Cannon LA; McGarry TF; Webster MW; Hall JJ; Lucca MJ; Mishkel GJ; Wu CJ; Mandinov L; Dawkins KD
    Cardiovasc Revasc Med; 2011; 12(4):247-57. PubMed ID: 21130708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
    Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
    Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus.
    Kimura M; Mintz GS; Weissman NJ; Dawkins KD; Grube E; Ellis SG; Cannon LA; Masud Z; Mandinov L; Baim D; Stone GW
    Am J Cardiol; 2008 May; 101(9):1263-8. PubMed ID: 18435955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.
    Steinberg DH; Mintz GS; Mandinov L; Yu A; Ellis SG; Grube E; Dawkins KD; Ormiston J; Turco MA; Stone GW; Weissman NJ
    JACC Cardiovasc Interv; 2010 May; 3(5):486-94. PubMed ID: 20488404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
    Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
    Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
    Kawaguchi R; Sabate M; Angiolillo DJ; Jimenez-Quevedo P; Suzuki N; Corros C; Futamatsu H; Alfonso F; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):125-32. PubMed ID: 17541725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
    Tanabe K; Serruys PW; Degertekin M; Guagliumi G; Grube E; Chan C; Munzel T; Belardi J; Ruzyllo W; Bilodeau L; Kelbaek H; Ormiston J; Dawkins K; Roy L; Strauss BH; Disco C; Koglin J; Russell ME; Colombo A;
    Circulation; 2004 Jan; 109(2):196-200. PubMed ID: 14691036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
    Aoki J; Colombo A; Dudek D; Banning AP; Drzewiecki J; Zmudka K; Schiele F; Russell ME; Koglin J; Serruys PW;
    Circulation; 2005 Dec; 112(25):3876-83. PubMed ID: 16344384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents.
    Liu J; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW
    Am J Cardiol; 2009 Feb; 103(4):501-6. PubMed ID: 19195510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
    Kobayashi N; Maehara A; Allocco D; Witzenbichler B; Ellis SG; Turco MA; Ormiston JA; Guagliumi G; Jiang S; McAndrew TC; Dawkins KD; Stone GW; Mintz GS; Weissman NJ
    Coron Artery Dis; 2014 Nov; 25(7):575-81. PubMed ID: 24911615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
    Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.